A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 report).; 2021.
   Google Scholar
• Blanco I, Diego I, Bueno P, et al. Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique. Int J Chron Obstruct Pulmon Dis. 2017;13:57–67. doi:10.2147/COPD.S150853
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. Cifras de población. Provisionales a 1 de julio de 2020. Población residente por fecha, sexo y edad [National Institute of Statistics. Population data. Provisional on 1 july 2020. Population residing by date, sex, and age]. INE; 2020. Available from: https://www.ine.es/jaxiT3/Datos.htm?t=31304. Accessed June 17, 2021. Spanish.
   Google Scholar
• Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2020. doi:10.1016/j.arbres.2020.07.024
   Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868. doi:10.1136/thx.2009.115725
   PubMed Web of Science ®Google Scholar
• Institute for Health Metrics and Evaluation. Chronic obstructive pulmonary disease. Level 3 cause; 2019. Available from: http://www.healthdata.org/results/gbd_summaries/2019/chronic-obstructive-pulmonary-disease-level-3-cause. Accessed June 17, 2021.
   Google Scholar
• Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Western Europe. Institute for Health Metrics and Evaluation; 2019. Available from: http://ghdx.healthdata.org/gbd-results-tool. Accessed January 21, 2022.
   Google Scholar
• Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Spain. Institute for Health Metrics and Evaluation; 2019. Available from: http://ghdx.healthdata.org/gbd-results-tool. Accessed June 17, 2021.
   Google Scholar
• Country profile: Spain. Institute for Health Metrics and Evaluation; 2019. Available from: http://www.healthdata.org/spain. Accessed June 17, 2021.
   Google Scholar
• Merino M, Villoro R, Hidalgo-Vega Á, Carmona C. Social economic costs of COPD in Extremadura (Spain): an observational study. Int J Chron Obstruct Pulmon Dis. 2018;13:2501–2514. doi:10.2147/COPD.S167357
   PubMed Web of Science ®Google Scholar
• Bouza E, Alvar A, Almagro P, et al. Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document. Rev Esp Quimioter. 2020;33(1):49–67. doi:10.37201/req/2064.2019
   PubMed Web of Science ®Google Scholar
• Arriero‐Marín JM, Orozco‐Beltrán D, Carratalá‐Munuera C, et al. A modified Delphi consensus study to identify improvement proposals for COPD management amongst clinicians and administrators in Spain. Int J Clin Pract. 2021;75(5). doi:10.1111/ijcp.13934
   PubMed Web of Science ®Google Scholar
• Ancochea J, Aguilar J, de Lucas P, et al. La epoc en España: reflexión sobre la situación actual y propuesta de soluciones 2021 [COPD in Spain: thoughts on the current situation and proposals on solutions 2021]. EIDON. 2020;54:151–187. Spanish. doi:10.13184/eidon.54.2020.151-187
   Google Scholar
• Ancochea J, Soriano JB. COPD in Spain at the start of a new decade. Arch Bronconeumol. 2021;57(1):1–2. doi:10.1016/j.arbres.2020.01.025
   Web of Science ®Google Scholar
• Yates BT, Marra M. Social Return On Investment (SROI): problems, solutions … and is SROI a good investment? Eval Program Plann. 2017;64:136–144. doi:10.1016/j.evalprogplan.2016.11.009
   PubMed Web of Science ®Google Scholar
• Nicholls J, Lawlor E, Neitzert E, Goodspeed T. A guide to social return on investment. 2nd ed. The SROI network. accounting for value; 2012. Available from: http://www.socialvalueuk.org/app/uploads/2016/03/The%20Guide%20to%20Social%20Return%20on%20Investment%202015.pdf. Accessed June 07, 2022.
   Google Scholar
• Nicholls J. Social return on investment—development and convergence. Eval Program Plann. 2017;64:127–135. doi:10.1016/j.evalprogplan.2016.11.011
   PubMed Web of Science ®Google Scholar
• Banke-Thomas AO, Madaj B, Charles A, van den Broek N. Social Return on Investment (SROI) methodology to account for value for money of public health interventions: a systematic review. BMC Public Health. 2015;15(1):582–595. doi:10.1186/s12889-015-1935-7
   PubMed Web of Science ®Google Scholar
• Nielsen JG, Lueg R, Liempd DV. Challenges and boundaries in implementing social return on investment: an inquiry into its situational appropriateness. Nonprofit Manag Leadersh. 2020;1–23. doi:10.1002/nml.21439
   Web of Science ®Google Scholar
• Masters R, Anwar E, Collins B, Cookson R, Capewell S. Return on investment of public health interventions: a systematic review. J Epidemiol Community Health. 2017;71(8):827–834. doi:10.1136/jech-2016-208141
   PubMed Web of Science ®Google Scholar
• Gosselin V, Boccanfuso D, Laberge S. Social return on investment (SROI) method to evaluate physical activity and sport interventions: a systematic review. Int J Behav Nutr Phys Act. 2020;17(1):26. doi:10.1186/s12966-020-00931-w
   PubMed Web of Science ®Google Scholar
• Ashton K, Schröder-Bäck P, Clemens T, Dyakova M, Stielke A, Bellis MA. The social value of investing in public health across the life course: a systematic scoping review. BMC Public Health. 2020;20(1):597. doi:10.1186/s12889-020-08685-7
   PubMed Web of Science ®Google Scholar
• Hutchinson CL, Berndt A, Forsythe D, Gilbert-Hunt S, George S, Ratcliffe J. Valuing the impact of health and social care programs using social return on investment analysis: how have academics advanced the methodology? A systematic review. BMJ Open. 2019;9(8):e029789. doi:10.1136/bmjopen-2019-029789
   PubMed Web of Science ®Google Scholar
• Jones C, Hartfiel N, Brocklehurst P, Lynch M, Edwards RT. Social return on investment analysis of the health precinct community hub for chronic conditions. Int J Environ Res Public Health. 2020;17(14):5249. doi:10.3390/ijerph17145249
   PubMed Web of Science ®Google Scholar
• Merino M, Jiménez M, Manito N, et al. The social return on investment of a new approach to heart failure in the Spanish National Health System. ESC Heart Fail. 2020;7(1):130–137. doi:10.1002/ehf2.12535
   PubMed Web of Science ®Google Scholar
• Carretero G, Moreno D, González Domínguez A, et al. Multidisciplinary approach to psoriasis in the Spanish National Health System: a social return on investment study. Glob Reg Health Technol Assess. 2020;7(1):50–56. doi:10.33393/grhta.2020.2146
   Web of Science ®Google Scholar
• Moral Torres E, Fernández Fernández Ó, Carrascal Rueda P, et al. Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study. BMC Health Serv Res. 2020;20(1):1–16. doi:10.1186/s12913-020-4946-8
   Web of Science ®Google Scholar
• Merino M, Ivanova Y, Martín Lorenzo T, Hidalgo-Vega Á. Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study. Clin Exp Rheumatol. 2022;40:104–111. doi:10.55563/clinexprheumatol/mh38sy
   PubMed Web of Science ®Google Scholar
• Soto I, Mateo J, García-Diego DA, et al. The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC Health Serv Res. 2022;22(1):115. doi:10.1186/s12913-021-07447-4
   PubMed Web of Science ®Google Scholar
• Ministerio de Sanidad, Consumo y Bienestar Social. Estadística de gasto sanitario público 2019. Principales resultados [Public health expenditure statistics 2019. Main results]; 2021. Spanish.
   Google Scholar
• de Miguel-Díez J, Carrasco-Garrido P, Rejas-Gutierrez J, et al. Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status. Lung. 2011;189(3):199–206. doi:10.1007/s00408-011-9289-0
   PubMed Web of Science ®Google Scholar
• Ulrik CS, Hansen EF, Jensen MS, et al. Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines. Int J Chron Obstruct Pulmon Dis. 2010;5:73–79. doi:10.2147/copd.s9102
   PubMedGoogle Scholar
• Puente-Maestu L, Calle M, Rodríguez-Hermosa JL, et al. Health literacy and health outcomes in chronic obstructive pulmonary disease. Respir Med. 2016;115:78–82. doi:10.1016/j.rmed.2016.04.016
   PubMed Web of Science ®Google Scholar
• Amado CA, Pérez-García C, Fernández BT, Agüero-Calvo J, Muñoz-Cacho P, Golpe R. Information needs in COPD after an educational programme: influence in exacerbations and admissions. Int J Chron Obstruct Pulmon Dis. 2020;15:2663–2671. doi:10.2147/COPD.S275002
   PubMed Web of Science ®Google Scholar
• Trapero‐Bertran M, Muñoz C, Coyle K, et al. Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD. Addict Abingdon Engl. 2018;113(Suppl 1):65–75. doi:10.1111/add.14090
   PubMed Web of Science ®Google Scholar
• Observatorio Español de las Drogas y las Adicciones. Encuesta sobre alcohol y otras drogas en España, EDADES 2019/20. [Survey on alcohol and other drugs in Spain, EDADES 2019/20]. Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas. 2021. Spanish.
   Google Scholar
• Lopez-Campos JL, Almagro P, Gómez JT, et al. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos [Update on the Spanish COPD guideline (GesEPOC): comorbidities, self-care, and palliative care]. Arch Bronconeumol. 2021:S0300289621002167. Spanish. doi:10.1016/j.arbres.2021.08.002
   Google Scholar
• Pullen R, Miravitlles M, Sharma A, et al. CONQUEST quality standards: for the collaboration on quality improvement initiative for achieving excellence in standards of COPD care. Int J Chron Obstruct Pulmon Dis. 2021;16:2301–2322. doi:10.2147/COPD.S313498
   PubMed Web of Science ®Google Scholar
• Banke-Thomas A. What about the issues in using social return on investment as an evaluation tool? Eval J Australas. 2018;18(1):64–68. doi:10.1177/1035719X17753984
   Google Scholar
• Pokhrel S. Return on investment (ROI) modelling in public health: strengths and limitations. Eur J Public Health. 2015;25(6):908–909. doi:10.1093/eurpub/ckv136
   PubMed Web of Science ®Google Scholar